HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
mutein TNF 471
an apoptosis-inducing gene therapy for pancreatic cancer
Also Known As:
tumor necrosis factor-471
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Carbohydrates: 22023
Glycoconjugates: 1353
Glycoproteins: 24834
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Intercellular Signaling Peptides and Proteins: 29768
Cytokines: 164289
Monokines: 214
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Tumor Necrosis Factors: 152
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Glycoproteins: 24834
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Blood Proteins: 12459
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Peptides: 82426
Intercellular Signaling Peptides and Proteins: 29768
Cytokines: 164289
Monokines: 214
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Tumor Necrosis Factors: 152
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Biological Factors: 2472
Intercellular Signaling Peptides and Proteins: 29768
Cytokines: 164289
Monokines: 214
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Tumor Necrosis Factors: 152
Tumor Necrosis Factor-alpha: 62515
mutein TNF 471: 1
Related Diseases
1.
Pancreatic Neoplasms (Pancreatic Cancer)
04/15/1998 - "
Thus, gene therapy combining transfection of the TNF-R55 gene with administration of mutein TNF 471 may provide a new modality for the treatment of pancreatic cancer.
"